TickerFacts.

PMGC Holdings Inc. (ELAB): Revenue

Annual figures by period end, from SEC filings.

$590.1K
Year ended 2025-12-31
-8.3%
3-year compound annual growth
$1.71M2022-12-31: $766.3K2023-12-31: $1.71M2025-12-31: $590.1K$590.1K
2022-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$590.1Kn/a2026-03-30, From 2025-01-01
No annual figure between 2023-12-31 and 2025-12-31.
2023-12-31$1.71M+123.5%2024-03-29, From 2023-01-01
2022-12-31$766.3Kn/a2024-03-29, From 2022-01-01

Revenue at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
PMGC Holdings Inc. (ELAB)2025-12-31$590.1Kn/a
Vaccinex, Inc. (VCNX)2024-12-31$601.0K+5.4%
Yarrow Bioscience, Inc. (YARW)2025-12-31$570.0K+13.8%
Silence Therapeutics plc (SLN)2025-12-31$559.0K-98.7%
BioXcel Therapeutics, Inc. (BTAIQ)2025-12-31$642.0K-71.7%
Polomar Health Services, Inc. (PMHS)2025-12-31$648.2Kn/m
Quantum Cyber N.V. (QUCY)2025-12-31$537.1K-39.9%
Lipella Pharmaceuticals Inc. (LIPO)2024-12-31$536.4K+19.3%
Mereo BioPharma Group plc (MREO)2025-12-31$500.0Kn/a

Compare ELAB, VCNX, YARW, SLN side by side · Screen every company in Pharmaceutical Preparations ↗